Around the world, work to improve our understanding of bleeding disorders and find new, improved ways of treating them is advancing all the time.
Research by the global pharmaceutical industry has already revolutionised the lives of people in many parts of the world through the development of manufactured ‘recombinant’ factor replacement treatment. As a result, young people diagnosed today can expect to lead a relatively normal and long life, with far less pain and disability than previous generations.
Focal points for current research include
- Reducing the challenges of treatment regimes through longer-lasting treatment
- Working towards a ‘cure’, through emerging approaches like gene therapy
- Understanding the burden a bleeding disorder has on life for people with haemophilia
Thanks to ongoing investment and expertise from the scientific research community, the future looks bright.